Pefloxacin versus levofloxacin in the treatment efficacy evaluation of lower respiratory tract infection.docVIP
- 0
- 0
- 约7.68千字
- 约 8页
- 2017-05-05 发布于浙江
- 举报
Pefloxacin versus levofloxacin in the treatment efficacy evaluation of lower respiratory tract infection
PAGE \* MERGEFORMAT 8
Pefloxacin versus levofloxacin in the treatment efficacy evaluation of lower respiratory tract infection
[Abstract] Objective: To compare the Pefloxacin and Ofloxacin in the treatment of lower respiratory tract infection efficacy, adverse reactions. Methods: 117 patients with lower respiratory tract infection were divided into two groups: Pefloxacin treatment group 60 cases, 0.4 g 2 times / d, intravenous drip, levofloxacin treatment group, 57 cases, 0.3 g 2 times / d, intravenous drip, course of treatment are 7 d ~ 14 d. Results: pefloxacin and levofloxacin in the treatment of lower respiratory tract infection efficiency was 90.0% and 87.5%, cure rates were 76.8% and 77.2%, no significant difference. Conclusion: pefloxacin and levofloxacin in the treatment of lower respiratory tract infection is similar to the clinical effect and adverse reactions.
[Keywords:] Pefloxacin; levofloxacin; lower respiratory tract infection
Evaluation Levofloxacin and Pefloxacin Treatment Subrespistory Tract Infection Effects
Abstract: Objective To stuy effective, side effective of levofloxacin and pefloxacinto cure subrespistory tract infection.Methods 117 patients were randonmly divided into two groups (60 samples) was given pefloxacin 0.4g iv bid 7 ~ 14 days.another group (57 samples) was given levofloxacin 0.3g, iv bid 7 ~ 14 days. Results The total response rate oflevofloxacin and pefloxacin were 87.7%, 90.0%, the total cure rate of levofloxacin and pefloxacin were, 77.2%, 76.8%. ther was no significant difference. Conclusion Effects side of levofloxacin and pefloxacin in treating subrespistory tract infection were simlar.
Keywords:: Pefloxacin; Levofloxacin; Subrespistory
Lower respiratory tract bacterial infections (community-acquired and hospital-acquired) in the clinical is common and frequently-occurring disease, particularly in hospital-acquired lower respiratory tract infection. In recent years, morbidity and mortality of the upw
您可能关注的文档
- Patients with severe traumatic brain injury care and prevention of bedsores.doc
- Patients with type 2 diabetes mellitus carotid artery intima - media thickness and plasma LPA content in the relationship between the.doc
- Patients with type 2 diabetes in community health education needs and to implement measures to.doc
- Patients with tuberculous pleurisy clinical analysis.doc
- Patients with type 2 diabetes status of the epidemiology of the major causes of death.doc
- Patients with wet age-related macular degeneration quality of life survey and efficacy of photodynamic therapy.doc
- Patients without appendicitis Cause of compliance behavior and health education.doc
- Patients with unstable angina in the coronary circulation changes in coagulation and fibrinolysis.doc
- Patients with type 2 diabetes the effect of individual evaluation of health education.doc
- Patrinia intervention on the effect of peritoneal adhesions.doc
- 商业航天的融资渠道与风险研究_2026年1月.docx
- 智慧路灯与城市安防联动布控策略研究_2026年1月.docx
- 元宇宙实验室在工科教学中的沉浸效果评估_2026年1月.docx
- 某公司获国际海底管理局许可采矿但环保组织抗议破坏未知生态系统_2026年1月.docx
- 2026年及未来5年市场数据中国网约车行业发展前景预测及投资战略研究报告.docx
- 2026年及未来5年市场数据中国网络零售产业竞争现状及十五五投资动向研究报告.docx
- 2026年及未来5年市场数据中国卫星通信设备行业市场需求与投资战略规划分析报告.docx
- 2026年及未来5年市场数据中国卫星导航市场竞争力分析及投资战略预测研发报告.docx
- 2026年及未来5年市场数据中国网络教育行业前景研究与投资战略研究报告.docx
- 2026年及未来5年市场数据中国微型滤波器行业市场专项调研及投资前景可行性预测报告.docx
原创力文档

文档评论(0)